CLINICAL_TRIALS
trial_result
· 2020-03-23
Clinical Trial Update: A Study of Tadalafil in Pediatric Participants With Pulmonary Arterial Hypertension (PAH) [Phase 3]
Summary
Phase 3 trial update for tadalafil in pediatric pulmonary arterial hypertension has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Hypertension, Pulmonary | Phase 3 | Status: COMPLETED | Results posted: 2020-03-23